Patients aged more than 70 had higher risk of locally advanced prostate cancers and biochemical recurrence in Korea

BJU International

Volumn 110, Issue 4, 2012, Pages 505-509

  Kim, Jung Kwon ^b   Cho, Sung Yong ^a   Jeong, Chang Wook ^c   Lee, Seung Bae ^a   Ku, Ja Hyeon ^b   Hong, Sung Kyu ^c   Byun, Seok Soo ^c   Kwak, Cheol ^b   Him, Hyeon Hoe ^b   Lee, Sang Eun ^c   Jeong, Hyeon ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

age; prostate specific antigen; prostatic neoplasm; radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER RECURRENCE; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; KAPLAN MEIER METHOD; LOCALLY ADVANCED PROSTATE CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SOUTH KOREA;

AGE FACTORS; AGED; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864456300     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10927.x     Document Type: Article

References (22)

1. Bechis SK, Carroll PR, Cooperberg MR,. Impact of age at diagnosis on prostate cancer treatment and survival. J Urol 2005; 29: 235-41
2. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 185-91
3. Lu-Yao GL, Albertsen PC, Moore DF, et al,. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA 2008; 300: 173-81 (Pubitemid 351969301)
4. Richstone L, Bianco FJ, Shah HH, et al,. Radical prostatectomy in men aged ≥70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram. BJU Int 2008; 101: 541-6 (Pubitemid 351199287)
5. Robinson D, Aus G, Bak J, et al,. Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007; 41: 103-9 (Pubitemid 46598091)
6. Konety BR, Cowan JE, Carroll PR,. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE. J Urol 2008; 179: 1797-803
7. Greco KA, Meeks JJ, Wu S, Nadler RB,. Robot-assisted radical prostatectomy in men aged ≥70 years. BJU Int 2009; 104: 1492-5
8. Pfitzenmaier J, Pahernik S, Buse S, et al,. Survival in prostate cancer patients ≥70 years after radical prostatectomy and comparison to younger patients. World J Urol 2009; 27: 637-42
9. Schwartz KL, Alibhai SM, Tomlinson G, et al,. Continued undertreatment of older men with localized prostate cancer. Urology 2003; 62: 860-5 (Pubitemid 37421232)
10. Heinzer H, Steuber T,. Prostate cancer in the elderly. Urol Oncol 2009; 27: 668
11. Greene KL, Albertsen PC, Babaian RJ, et al,. Prostate specific antigen best practice statement: 2009 update. J Urol 2009; 182: 2232-41
12. Bill-Axelson A, Holmberg L, Filen F, et al,. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008; 100: 1144-54
13. Cooperberg MR, Cowan J, Broering JM, Carroll PR,. High-risk prostate cancer in the United States, 1990-2007. World J Urol 2008; 26: 211-8
14. Crawford ED,. Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology 2009; 73: S4-S10
15. Sun L, Caire AA, Robertson CN, et al,. Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras. J Urol 2009; 182: 2242-8
16. Wong YN, Mitra N, Hudes G, et al,. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006; 296: 2683-93 (Pubitemid 44917546)
17. Alibhai SM, Naglie G, Nam R, et al,. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003; 21: 3318-27 (Pubitemid 46606266)
18. Hoffman KE, Chen MH, Moran BJ, et al,. Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer. Cancer 2010; 116: 2590-5
19. Hoffman KE, Nguyen PL, Ng AK, D'Amico AV,. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. J Urol 2010; 183: 1798-802
20. Nguyen PL, Chen MH, Renshaw AA, et al,. Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendations. Int J Radiat Oncol Biol Phys 2010; 76: 337-41
21. Albertsen PC, Hanley JA, Gleason DF, Barry MJ,. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280: 975-80 (Pubitemid 28445095)
22. Vickers AJ, Bianco FJ, Serio AM, et al,. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 2007; 99: 1171-7 (Pubitemid 47233067)